ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


ReNeuron Group plc.
79 announcements.
Time Ticker Company Announcement
07:00 RENE ReNeuron Group plc
ReNeuron's lead cell line shows further potential
17:36 RENE ReNeuron Group plc
Notification of Major Holdings
15:21 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Positive clinical data presented at AAO meeting
16:40 RENE ReNeuron Group plc
Second Price Monitoring Extn
16:35 RENE ReNeuron Group plc
Price Monitoring Extension
07:00 RENE ReNeuron Group plc
Clinical Update and Conference Presentations
11:21 RENE ReNeuron Group plc
Result of AGM
07:00 RENE ReNeuron Group plc
AGM Trading Update
07:00 RENE ReNeuron Group plc
Block Listing Review and TVR
07:00 RENE ReNeuron Group plc
Appointments to Scientific Advisory Board
07:00 RENE ReNeuron Group plc
Grant-funded collaboration with exosome platform
16:00 RENE ReNeuron Group plc
Posting of Annual Report and Notice of AGM
13:12 RENE ReNeuron Group plc
Notification of Major Holdings
11:50 RENE ReNeuron Group plc
Total Voting Rights
07:00 RENE ReNeuron Group plc
Director/PDMR Interest in Shares & Share Options
07:00 RENE ReNeuron Group plc
Key patent grants expand exosome IP portfolio
07:00 RENE ReNeuron Group plc
Senior business development appointment
07:00 RENE ReNeuron Group plc
Preliminary Results
16:30 RENE ReNeuron Group plc
Notification of Major Holdings
11:00 RENE ReNeuron Group plc
Price Monitoring Extension
07:00 RENE ReNeuron Group plc
Total Voting Rights
16:01 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Webcast of Preliminary Results
11:09 RENE ReNeuron Group plc
ReNeuron wins Breakthrough of the Year Award
07:00 RENE ReNeuron Group plc
Total Voting Rights
07:00 RENE ReNeuron Group plc
Jefferies 2019 Global Healthcare Conference
17:05 RENE ReNeuron Group plc
Exercise of options, PDMR dealing and TVR
07:00 RENE ReNeuron Group plc
Year-end update and results notification
15:43 RENE ReNeuron Group plc
Total Voting Rights
07:00 RENE ReNeuron Group plc
Clinical update and conference presentation
14:36 RENE ReNeuron Group plc
Exercise of Share Options and TVR
14:37 RENE ReNeuron Group plc
Director/PDMR Shares and Share Options
09:50 RENE ReNeuron Group plc
ReNeuron partners with Fosun Pharma in China
07:00 RENE ReNeuron Group plc
ReNeuron to present at UK investor conference
07:00 RENE ReNeuron Group plc
Clinical update and conference presentation
14:05 RENE ReNeuron Group plc
Second Price Monitoring Extn
14:00 RENE ReNeuron Group plc
Price Monitoring Extension
12:00 RENE ReNeuron Group plc
Alliance for Regenerative Medicine presentation
07:00 RENE ReNeuron Group plc
Retinal clinical trial progresses to next stage
14:30 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Block Listing Review and Total Voting Rights
07:00 RENE ReNeuron Group plc
Positive preliminary data in US retinal trial
07:00 RENE ReNeuron Group plc
New exosome production scale-up data presented
07:00 RENE ReNeuron Group plc
First patient treated in US stroke trial
07:00 RENE ReNeuron Group plc
ReNeuron signs exosome collaboration
07:00 RENE ReNeuron Group plc
Interim Results
14:00 RENE ReNeuron Group plc
Notification of Interim Results
07:00 RENE ReNeuron Group plc
ReNeuron's lead cell line shows further potential
14:16 RENE ReNeuron Group plc
Director/PDMR Interest in Shares and Share Options
15:02 RENE ReNeuron Group plc
Directors Share Purchases
16:40 RENE ReNeuron Group plc
Second Price Monitoring Extn
16:35 RENE ReNeuron Group plc
Price Monitoring Extension
07:00 RENE ReNeuron Group plc
Business development update
11:40 RENE ReNeuron Group plc
Result of AGM
07:00 RENE ReNeuron Group plc
AGM Trading Update
07:00 RENE ReNeuron Group plc
Block Listing Review and TVR
15:25 RENE ReNeuron Group plc
Posting of Annual Report & Notice of AGM
15:39 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Notification of Major Holdings
11:50 RENE ReNeuron Group plc
Notification of Major Holdings
07:00 RENE ReNeuron Group plc
Preliminary Results
07:00 RENE ReNeuron Group plc
Signs retinal stem cell exclusivity agreement
14:15 RENE ReNeuron Group plc
Notification of Preliminary Results
07:00 RENE ReNeuron Group plc
Proposed Share Capital Reorganisation
07:00 RENE ReNeuron Group plc
Further re Share Capital Reorganisation
11:06 RENE ReNeuron Group plc
Approval of Share Capital Reorganisation
07:00 RENE ReNeuron Group plc
Phase II stroke data presented at AHA conference
10:00 RENE ReNeuron Group plc
Positive pre-clinical data in nerve injury
07:00 RENE ReNeuron Group plc
Block Listing Application
07:00 RENE ReNeuron Group plc
Block Listing Review and TVR
07:00 RENE ReNeuron Group plc
Product Development Update
13:00 RENE ReNeuron Group plc
Appointment of US-based Chief Medical Officer
07:00 RENE ReNeuron Group plc
Wins grant for retinal cell therapy development
07:00 RENE ReNeuron Group plc
Capital Markets Event and Webcast
07:00 RENE ReNeuron Group plc
Capital Markets Event
07:00 RENE ReNeuron Group plc
Exosome data presented at ISCT conference